← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 7, 2020Last known activity
Sep 12, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 6 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT07182838CollaboratorEarly Phase 1Sep 12, 2025
- NCT07145333CollaboratorPhase 2/Phase 3Aug 12, 2025
- NCT07033585CollaboratorPhase 2/Phase 3Jun 15, 2025
- NCT06959563CollaboratorEarly Phase 1Apr 28, 2025
- NCT04656691Lead sponsorPhase 4Dec 31, 2020
- NCT04656691Sponsor investigatorPhase 4Dec 31, 2020
- NCT04353037Reponsible party - principal investigatorPhase 2Apr 7, 2020
- NCT04353037Overall official - principal investigatorPhase 2Apr 7, 2020
- NCT04353037Lead sponsorPhase 2Apr 7, 2020
- NCT04353037CollaboratorPhase 2Apr 7, 2020
Details
- Last known activity
- Sep 12, 2025